Antibiotic use and its consequences for the normal microbiome

Science

Volumn 352, Issue 6285, 2016, Pages 544-545

  Blaser, Martin J ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METFORMIN; PREBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; GENE EXPRESSION; METABOLITE; PUBLIC HEALTH;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL PRACTICE; HEALTH CARE; HUMAN; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; PHYSICIAN; PRIORITY JOURNAL; REVIEW; BACTERIUM; DRUG EFFECTS; DRUG UTILIZATION; MICROFLORA;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; MICROBIOTA;

EID: 84965058071     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aad9358     Document Type: Review

References (15)

1. T. P. Van Boeckel et al., Lancet Infect. Dis. 14, 742-750 (2014).
2. D. R. Zimmerman, J. Anim. Sci. 62 (suppl. 3), 6-16 (1986).
3. M. C. Arrieta et al., Sci. Transl. Med. 7, 307ra152 (2015).
4. M. B. Azad, S. L. Bridgman, A. B. Becker, A. L. Kozyrskyj, Int. J. Obes. (London) 38, 1290-1298 (2014).
5. I. Cho et al., Nature 488, 621-626 (2012).
6. L. M. Cox et al., Cell 158, 705-721 (2014).
7. T. Yatsunenko et al., Nature 486, 222-227 (2012).
8. M. J. Blaser, S. Falkow, Nat. Rev. Microbiol. 7, 887-894 (2009).
9. E. D. Sonnenburg et al., Nature 529, 212-215 (2016).
10. L. A. Hicks, T. H. Taylor Jr., R. J. Hunkler, N. Engl. J. Med. 368, 1461-1462 (2013).
11. Y. R. Nobel et al., Nat. Commun. 6, 7486 (2015).
12. K. Korpela et al., Nat. Commun. 7, 10410 (2016).
13. K. Forslund et al., Nature 528, 262-266 (2015).
14. K. H. Mikkelsen, F. K. Knop, M. Frost, J. Hallas, A. Pottegård, J. Clin. Endocrinol. Metab. 100, 3633-3640 (2015).
15. J. C. Clemente et al., Sci. Adv. 1, e1500183 (2015).